Opposite modulation of astroglial proliferation by adenosine 5'-O-(2-thio)-diphosphate and 2-methylthioadenosine-5'-diphosphate: Mechanisms involved

Neuroscience

Volumn 182, Issue , 2011, Pages 32-42

  Quintas, C ^a   Fraga, S ^a   Goncalves J ^a   Queiroz, G ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

A 2 receptors; A 3 receptors; Astroglial proliferation; Ectonucleotidases; P2Y 12 receptors; P2Y 1 receptors

Indexed keywords

2 METHYLTHIOADENOSINE; 2 METHYLTHIOADENOSINE 5' DIPHOSPHATE; ADENOSINE 5' O (2 THIODIPHOSPHATE); ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE DERIVATIVE; ADENOSINE TRIPHOSPHATE; CYCLIC AMP DEPENDENT PROTEIN KINASE; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PERTUSSIS TOXIN; PHOSPHOLIPASE C; PROTEIN KINASE C; PURINERGIC P2Y1 RECEPTOR; PURINERGIC P2Y12 RECEPTOR; PURINERGIC P2Y13 RECEPTOR; PURINERGIC RECEPTOR STIMULATING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASTROCYTE; ASTROCYTOSIS; CELL TRANSPORT; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME RELEASE; MOLECULAR MECHANICS; NERVE CELL NECROSIS; NEUROMODULATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ADENOSINE DIPHOSPHATE; ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; CELL PROLIFERATION; CELLS, CULTURED; PURINERGIC P2Y RECEPTOR AGONISTS; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P2Y1; RECEPTORS, PURINERGIC P2Y12; THIONUCLEOTIDES;

EID: 79955484486     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.03.009     Document Type: Article

References (52)

1. Abbracchio M.P., Burnstock G., Boeynaems J.M., Barnard E.A., Boyer J.L., Kennedy C., Knight G.E., Fumagalli M., Gachet C., Jacobson K.A., Weisman G.A. International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 2006, 58:281-341.
2. Abbracchio M.P., Burnstock G., Verkhratsky A., Zimmermann H. Purinergic signalling in the nervous system: an overview. Trends Neurosci 2009, 32:19-29.
3. Alvarado-Castillo C., Harden T.K., Boyer J.L. Regulation of P2Y1 receptor-mediated signaling by the ectonucleoside triphosphate diphosphohydrolase isozymes NTPDase1 and NTPDase2. Mol Pharmacol 2005, 67:114-122.
4. Anderson C.M., Bergher J.P., Swanson R.A. ATP-induced ATP release from astrocytes. J Neurochem 2004, 88:246-256.
5. Ayyanathan K., Webbs T.E., Sandhu A.K., Athwal R.S., Barnard E.A., Kunapuli S.P. Cloning and chromosomal localization of the human P2Y1 purinoceptor. Biochem Biophys Res Commun 1996, 218:783-788.
6. Baldwin S.A., Beal P.R., Yao S.Y., King A.E., Cass C.E., Young J.D. The equilibrative nucleoside transporter family, SLC29. Pflugers Arch 2004, 447:735-743.
7. Ballerini P., Rathbone M.P., Di Iorio P., Renzetti A., Giuliani P., D'Alimonte I., Trubiani O., Caciagli F., Ciccarelli R. Rat astroglial P2Z (P2X7) receptors regulate intracellular calcium and purine release. Neuroreport 1996, 7:2533-2537.
8. Boyer J.L., Mohanram A., Camaioni E., Jacobson K.A., Harden T.K. Competitive and selective antagonism of P2Y1 receptors by N6-methyl 2'-deoxyadenosine 3',5'-bisphosphate. Br J Pharmacol 1998, 124:1-3.
9. Ceruti S., Franceschi C., Barbieri D., Malorni W., Camurri A., Giammarioli A.M., Ambrosini A., Racagni G., Cattabeni F., Abbracchio M.P. Apoptosis induced by 2-chloro-adenosine and 2-chloro-2'-deoxy-adenosine in a human astrocytoma cell line: differential mechanisms and possible clinical relevance. J Neurosci Res 2000, 60:388-400.
10. Ciccarelli R., Di Iorio P., Ballerini P., Ambrosini G., Giuliani P., Tiboni G.M., Caciagli F. Effects of exogenous ATP and related analogues on the proliferation rate of dissociated primary cultures of rat astrocytes. J Neurosci Res 1994, 39:556-566.
11. Coco S., Calegari F., Pravettoni E., Pozzi D., Taverna E., Rosa P., Matteoli M., Verderio C. Storage and release of ATP from astrocytes in culture. J Biol Chem 2003, 278:1354-1362.
12. Czajkowski R., Banachewicz W., Ilnytska O., Drobot L.B., Baranska J. Differential effects of P2Y1 and P2Y12 nucleotide receptors on ERK1/ERK2 and phosphatidylinositol 3-kinase signalling and cell proliferation in serum-deprived and nonstarved glioma C6 cells. Br J Pharmacol 2004, 141:497-507.
13. Di Iorio P., Kleywegt S., Ciccarelli R., Traversa U., Andrew C.M., Crocker C.E., Werstiuk E.S., Rathbone M.P. Mechanisms of apoptosis induced by purine nucleosides in astrocytes. Glia 2002, 38:179-190.
14. Di Virgilio F., Ceruti S., Bramanti P., Abbracchio M.P. Purinergic signalling in inflammation of the central nervous system. Trends Neurosci 2009, 32:79-87.
15. Dorostkar M.M., Boehm S. Presynaptic ionotropic receptors. Handbook of Experimental Pharmacology 2008, 479-527. Springer, Heidelberg. Vol. 184. T. Südhof, K. Starke (Eds.).
16. Franke H., Krügel U., Grosche J., Heine C., Härtig W., Allgaier C., Illes P. P2Y receptor expression on astrocytes in the nucleus accumbens of rats. Neuroscience 2004, 127:431-441.
17. Franke H., Sauer C., Rudolph C., Krügel U., Hengstler J.G., Illes P. P2 receptor-mediated stimulation of the PI3-K/Akt-pathway in vivo. Glia 2009, 57:1031-1045.
18. Gendaszewska-Darmach E., Maszewska M., Zaklos M., Koziolkiewicz M. Degradation of extracellular nucleotides and their analogs in HeLa and HUVEC cell cultures. Acta Biochim Pol 2003, 50:973-984.
19. Gonçalves J., Queiroz G. Presynaptic adenosine and P2Y receptors. Handbook of Experimental Pharmacology 2008, 339-372. Springer, Heidelberg. Vol. 184. T. Südhof, K. Starke (Eds.).
20. Gray J.H., Owen R.P., Giacomini K.M. The concentrative nucleoside transporter family, SLC28. Pflugers Arch 2004, 447:728-734.
21. Hamby M.E., Uliasz T.F., Hewett S.J., Hewett J.A. Characterization of an improved procedure for the removal of microglia from confluent monolayers of primary astrocytes. J Neurosci Methods 2006, 150:128-137.
22. Haskó G., Pacher P., Vizi E.S., Illes P. Adenosine receptor signaling in the brain immune system. Trends Pharmacol Sci 2005, 26:511-516.
23. Haydon P.G. GLIA: listening and talking to the synapse. Nat Rev Neurosci 2001, 2:185-193.
24. Hoffmann C., Moro S., Nicholas R.A., Harden T.K., Jacobson K.A. The role of amino acids in extracellular loops of the human P2Y1 receptor in surface expression and activation processes. J Biol Chem 1999, 274:14639-14647.
25. Ingall A.H., Dixon J., Bailey A., Coombs M.E., Cox D., McInally J.I., Hunt S.F., Kindon N.D., Teobald B.J., Willis P.A., Humphries R.G., Leff P., Clegg J.A., Smith J.A., Tomlinson W. Antagonists of the platelet P2T receptor: a novel approach to antithrombotic therapy. J Med Chem 1999, 42:213-220.
26. Iqbal J., Vollmayer P., Braun N., Zimmermann H., Müller C.E. A capillary electrophoresis method for the characterization of ecto-nucleoside triphosphate diphosphohydrolases (NTPDases) and the analysis of inhibitors by in-capillary enzymatic microreaction. Purinergic Signal 2005, 1:349-358.
27. Ke R.H., Xiong J., Liu Y., Ye Z.R. Adenosine A2A receptor induced gliosis via Akt/NF-kappaB pathway in vitro. Neurosci Res 2009, 65:280-285.
28. Kim Y.C., Lee J.S., Sak K., Marteau F., Mamedova L., Boeynaems J.M., Jacobson K.A. Synthesis of pyridoxal phosphate derivatives with antagonist activity at the P2Y13 receptor. Biochem Pharmacol 2005, 70:266-274.
29. Li A.H., Moro S., Melman N., Ji X.D., Jacobson K.A. Structure-activity relationships and molecular modeling of 3,5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists. J Med Chem 1998, 41:3186-3201.
30. Lohse M.J., Klotz K.N., Lindenborn-Fotinos J., Reddington M., Schwabe U., Olsson R.A. 8-Cyclopentyl-1,3-dipropylxanthine (DPCPX)-a selective high affinity antagonist radioligand for A1 adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol 1987, 336:204-210.
31. Molina-Arcas M., Casado F.J., Pastor-Anglada M. Nucleoside transporter proteins. Curr Vasc Pharmacol 2009, 7:426-434.
32. Munkonda M.N., Kauffenstein G., Kukulski F., Lévesque S.A., Legendre C., Pelletier J., Lavoie E.G., Lecka J., Sévigny J. Inhibition of human and mouse plasma membrane bound NTPDases by P2 receptor antagonists. Biochem Pharmacol 2007, 74:1524-1534.
33. Nagai K., Nagasawa K., Fujimoto S. Transport mechanisms for adenosine and uridine in primary-cultured rat cortical neurons and astrocytes. Biochem Biophys Res Commun 2005, 334:1343-1350.
34. Neary J.T., Baker L., Jorgensen S.L., Norenberg M.D. Extracellular ATP induces stellation and increases glial fibrillary acidic protein content and DNA synthesis in primary astrocyte cultures. Acta Neuropathol 1994, 87:8-13.
35. Neary J.T., Kang Y., Bu Y., Yu E., Akong K., Peters C.M. Mitogenic signaling by ATP/P2Y purinergic receptors in astrocytes: involvement of a calcium-independent protein kinase C, extracellular signal-regulated protein kinase pathway distinct from the phosphatidylinositol-specific phospholipase C/calcium pathway. J Neurosci 1999, 19:4211-4220.
36. Neary J.T., Kang Y., Willoughby K.A., Ellis E.F. Activation of extracellular signal-regulated kinase by stretch-induced injury in astrocytes involves extracellular ATP and P2 purinergic receptors. J Neurosci 2003, 23:2348-2356.
37. Perea G., Navarrete M., Araque A. Tripartite synapses: astrocytes process and control synaptic information. Trends Neurosci 2009, 32:421-431.
38. Queiroz G., Gebicke-Haerter P.J., Schobert A., Starke K., von Kügelgen I. Release of ATP from cultured rat astrocytes elicited by glutamate receptor activation. Neuroscience 1997, 78:1203-1208.
39. Schrier S.M., van Tilburg E.W., van der Meulen H., Ijzerman A.P., Mulder G.J., Nagelkerke J.F. Extracellular adenosine-induced apoptosis in mouse neuroblastoma cells: studies on involvement of adenosine receptors and adenosine uptake. Biochem Pharmacol 2001, 61:417-425.
40. Schulte G., Fredholm B.B. Signalling from adenosine receptors to mitogen-activated protein kinases. Cell Signal 2003, 15:813-827.
41. Sofroniew M.V., Vinters H.V. Astrocytes: biology and pathology. Acta Neuropathol 2010, 119:7-35.
42. Soulet C., Sauzeau V., Plantavid M., Herbert J.M., Pacaud P., Payrastre B., Savi P. Gi-dependent and -independent mechanisms downstream of the P2Y12 ADP-receptor. J Thromb Haemost 2004, 2:135-146.
43. Tonazzini I., Trincavelli M.L., Montali M., Martini C. Regulation of A1 adenosine receptor functioning induced by P2Y1 purinergic receptor activation in human astroglial cells. J Neurosci Res 2008, 86:2857-2866.
44. Van Kolen K., Slegers H. Atypical PKCζ is involved in RhoA-dependent mitogenic signaling by the P2Y12 receptor in C6 cells. FEBS J 2006, 273:1843-1854.
45. von Kügelgen I. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol Ther 2006, 110:415-432.
46. Waldo G.L., Harden T.K. Agonist binding and Gq-stimulating activities of the purified human P2Y1 receptor. Mol Pharmacol 2004, 65:426-436.
47. Wang L., Karlsson L., Moses S., Hultgardh-Nilsson A., Andersson M., Borna C., Gudbjartsson T., Jern S., Erlinge D. P2 receptor expression profiles in human vascular smooth muscle and endothelial cells. J Cardiovasc Pharmacol 2002, 40:841-853.
48. Wink M.R., Braganhol E., Tamajusuku A.S., Casali E.A., Karl J., Barreto-Chaves M.L., Sarkis J.J., Battastini A.M. Extracellular adenine nucleotides metabolism in astrocyte cultures from different brain regions. Neurochem Int 2003, 43:621-628.
49. Wink M.R., Braganhol E., Tamajusuku A.S., Lenz G., Zerbini L.F., Libermann T.A., Sévigny J., Battastini A.M., Robson S.C. Nucleoside triphosphate diphosphohydrolase-2 (NTPDase2/CD39L1) is the dominant ectonucleotidase expressed by rat astrocytes. Neuroscience 2006, 138:421-432.
50. Xu B., Stephens A., Kirschenheuter G., Greslin A.F., Cheng X., Sennelo J., Cattaneo M., Zighetti M.L., Chen A., Kim S.A., Kim H.S., Bischofberger N., Cook G., Jacobson K.A. Acyclic analogues of adenosine bisphosphates as P2Y receptor antagonists: phosphate substitution leads to multiple pathways of inhibition of platelet aggregation. J Med Chem 2002, 45:5694-5709.
51. Yegutkin G.G. Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade. Biochim Biophys Acta 2008, 1783:673-694.
52. Zimmermann H. Ectonucleotidases in the nervous system. Novartis Found Symp 2006, 276:113-128.